HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA commissioner search: Pittsburgh's Juhl could be politically appealing candidate.

This article was originally published in The Rose Sheet

Executive Summary

FDA COMMISSIONER SEARCH: PITTSBURGH PHARMACY PROFESSOR JUHL, one of the first names being widely discussed as a successor to Commissioner David Kessler could offer an appealing package of attributes considering the political environment surrounding the selection process. University of Pittsburgh School of Pharmacy Dean Randy Juhl, PhD, the inaugural chairman of FDA's Nonprescription Drugs Advisory Committee, could be presented as an advocate of consumer access to technologies and a progressive role for FDA within the total economy. He was a key participant in the agency's stepped up efforts to expand consumer access to medicines via the Rx-to-OTC switch process.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS003528

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel